Search

Sonya N. Wright

Examiner (ID: 11509, Phone: (571)272-5857 , Office: P/1672 )

Most Active Art Unit
1629
Art Unit(s)
1629, 1621, 1626, 1672, 1613, 1762, 1796, 1614
Total Applications
765
Issued Applications
560
Pending Applications
32
Abandoned Applications
177

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4383004 [patent_doc_number] => 06294541 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'Purine derivatives having phosphodiesterase IV inhibition activity' [patent_app_type] => 1 [patent_app_number] => 9/418330 [patent_app_country] => US [patent_app_date] => 1999-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10651 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 348 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294541.pdf [firstpage_image] =>[orig_patent_app_number] => 418330 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/418330
Purine derivatives having phosphodiesterase IV inhibition activity Oct 13, 1999 Issued
Array ( [id] => 4409889 [patent_doc_number] => 06300334 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Thieno[2,3-d]pyrimidine-2,4-diones' [patent_app_type] => 1 [patent_app_number] => 9/402837 [patent_app_country] => US [patent_app_date] => 1999-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23178 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 783 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300334.pdf [firstpage_image] =>[orig_patent_app_number] => 402837 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/402837
Thieno[2,3-d]pyrimidine-2,4-diones Oct 12, 1999 Issued
Array ( [id] => 4420493 [patent_doc_number] => 06194576 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Process for preparing antiviral 2-phosponate nucleotide analogs' [patent_app_type] => 1 [patent_app_number] => 9/411980 [patent_app_country] => US [patent_app_date] => 1999-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41846 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 412 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194576.pdf [firstpage_image] =>[orig_patent_app_number] => 411980 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/411980
Process for preparing antiviral 2-phosponate nucleotide analogs Oct 3, 1999 Issued
Array ( [id] => 4307008 [patent_doc_number] => 06252067 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Method of preparing oxoquazepam' [patent_app_type] => 1 [patent_app_number] => 9/410031 [patent_app_country] => US [patent_app_date] => 1999-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1069 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/252/06252067.pdf [firstpage_image] =>[orig_patent_app_number] => 410031 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/410031
Method of preparing oxoquazepam Sep 30, 1999 Issued
Array ( [id] => 4411820 [patent_doc_number] => 06300495 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Process for the preparation of a metal salt of clavulanic acid' [patent_app_type] => 1 [patent_app_number] => 9/402231 [patent_app_country] => US [patent_app_date] => 1999-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4517 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300495.pdf [firstpage_image] =>[orig_patent_app_number] => 402231 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/402231
Process for the preparation of a metal salt of clavulanic acid Sep 29, 1999 Issued
Array ( [id] => 4383502 [patent_doc_number] => 06277857 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Fungicidal 7-oxy-and 7-thio-substituted-triazolopyrimidines' [patent_app_type] => 1 [patent_app_number] => 9/405412 [patent_app_country] => US [patent_app_date] => 1999-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6235 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277857.pdf [firstpage_image] =>[orig_patent_app_number] => 405412 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/405412
Fungicidal 7-oxy-and 7-thio-substituted-triazolopyrimidines Sep 23, 1999 Issued
Array ( [id] => 4185593 [patent_doc_number] => 06159974 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'LDL receptor gene expression promoters' [patent_app_type] => 1 [patent_app_number] => 9/381829 [patent_app_country] => US [patent_app_date] => 1999-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11284 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159974.pdf [firstpage_image] =>[orig_patent_app_number] => 381829 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/381829
LDL receptor gene expression promoters Sep 23, 1999 Issued
Array ( [id] => 4304685 [patent_doc_number] => 06187781 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => '4-Tetrahydropyridylpyrimidine derivatives' [patent_app_type] => 1 [patent_app_number] => 9/381462 [patent_app_country] => US [patent_app_date] => 1999-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9522 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187781.pdf [firstpage_image] =>[orig_patent_app_number] => 381462 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/381462
4-Tetrahydropyridylpyrimidine derivatives Sep 20, 1999 Issued
Array ( [id] => 4383286 [patent_doc_number] => 06277844 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis' [patent_app_type] => 1 [patent_app_number] => 9/395812 [patent_app_country] => US [patent_app_date] => 1999-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 15 [patent_no_of_words] => 9516 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277844.pdf [firstpage_image] =>[orig_patent_app_number] => 395812 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/395812
Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis Sep 13, 1999 Issued
09/380380 COMPOUNDS Aug 31, 1999 Abandoned
Array ( [id] => 4420414 [patent_doc_number] => 06194569 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Efficient process for the preparation of [S-(R,S)]-N-[1,3-benzodioxol-5-yl)butyl]-3,3-diethyl-2[4-[4-methyl-1-piper azinyl)carbonyl]phenoxy]-4-oxo-1-azetidine carboxamide, a human leukocyte elastase inhibitor' [patent_app_type] => 1 [patent_app_number] => 9/385271 [patent_app_country] => US [patent_app_date] => 1999-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11066 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/194/06194569.pdf [firstpage_image] =>[orig_patent_app_number] => 385271 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/385271
Efficient process for the preparation of [S-(R,S)]-N-[1,3-benzodioxol-5-yl)butyl]-3,3-diethyl-2[4-[4-methyl-1-piper azinyl)carbonyl]phenoxy]-4-oxo-1-azetidine carboxamide, a human leukocyte elastase inhibitor Aug 29, 1999 Issued
Array ( [id] => 4316941 [patent_doc_number] => 06242599 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Process for the preparation of guanine' [patent_app_type] => 1 [patent_app_number] => 9/384215 [patent_app_country] => US [patent_app_date] => 1999-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1724 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242599.pdf [firstpage_image] =>[orig_patent_app_number] => 384215 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/384215
Process for the preparation of guanine Aug 26, 1999 Issued
Array ( [id] => 4371091 [patent_doc_number] => 06288075 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same' [patent_app_type] => 1 [patent_app_number] => 9/384237 [patent_app_country] => US [patent_app_date] => 1999-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36945 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288075.pdf [firstpage_image] =>[orig_patent_app_number] => 384237 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/384237
Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same Aug 26, 1999 Issued
Array ( [id] => 1470743 [patent_doc_number] => 06407236 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Adenosine A3 receptor modulators' [patent_app_type] => B1 [patent_app_number] => 09/379300 [patent_app_country] => US [patent_app_date] => 1999-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18962 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407236.pdf [firstpage_image] =>[orig_patent_app_number] => 09379300 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/379300
Adenosine A3 receptor modulators Aug 22, 1999 Issued
Array ( [id] => 1514810 [patent_doc_number] => 06420375 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Fused ring compounds, process for producing the same and use thereof' [patent_app_type] => B1 [patent_app_number] => 09/367896 [patent_app_country] => US [patent_app_date] => 1999-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28221 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420375.pdf [firstpage_image] =>[orig_patent_app_number] => 09367896 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/367896
Fused ring compounds, process for producing the same and use thereof Aug 17, 1999 Issued
Array ( [id] => 1507891 [patent_doc_number] => 06440972 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Heterocyclic compounds useful as oxido-squalene cyclase inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/367400 [patent_app_country] => US [patent_app_date] => 1999-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11243 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440972.pdf [firstpage_image] =>[orig_patent_app_number] => 09367400 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/367400
Heterocyclic compounds useful as oxido-squalene cyclase inhibitors Aug 12, 1999 Issued
Array ( [id] => 4326881 [patent_doc_number] => 06329382 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidine remedies/preventives for respiratory diseases' [patent_app_type] => 1 [patent_app_number] => 9/355935 [patent_app_country] => US [patent_app_date] => 1999-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9936 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329382.pdf [firstpage_image] =>[orig_patent_app_number] => 355935 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/355935
Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidine remedies/preventives for respiratory diseases Aug 12, 1999 Issued
Array ( [id] => 4251234 [patent_doc_number] => 06137007 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Enantiomer compositions of (1R,4S)-1-butyrylamino-4-(hydroxymethyl)-2-cyclopentene' [patent_app_type] => 1 [patent_app_number] => 9/373862 [patent_app_country] => US [patent_app_date] => 1999-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11003 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/137/06137007.pdf [firstpage_image] =>[orig_patent_app_number] => 373862 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/373862
Enantiomer compositions of (1R,4S)-1-butyrylamino-4-(hydroxymethyl)-2-cyclopentene Aug 12, 1999 Issued
Array ( [id] => 4352895 [patent_doc_number] => 06215004 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Method of manufacture of 1,3-oxathiolane nucleosides' [patent_app_type] => 1 [patent_app_number] => 9/373891 [patent_app_country] => US [patent_app_date] => 1999-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12245 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/215/06215004.pdf [firstpage_image] =>[orig_patent_app_number] => 373891 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/373891
Method of manufacture of 1,3-oxathiolane nucleosides Aug 11, 1999 Issued
09/367107 PROCESS FOR THE CRYSTALLIZATION FROM A LINEAR OR BRANCHED (C5-C6) ALCOHOL OR THEIR MIXTURES OF (S)-N,N'-BIS[2-HYDROXY-1-(HYDROXYMETHYL) ETHYL]-5-[(2-HYDROXY-1-OXOPROPY)AMINO]-2,4,6-TRIIODO-1,3- BENZENDICARBOXAMIDE Aug 9, 1999 Abandoned
Menu